Literature DB >> 18264114

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.

Shee-Mei Lok1, Victor Kostyuchenko, Grant E Nybakken, Heather A Holdaway, Anthony J Battisti, Soila Sukupolvi-Petty, Dagmar Sedlak, Daved H Fremont, Paul R Chipman, John T Roehrig, Michael S Diamond, Richard J Kuhn, Michael G Rossmann.   

Abstract

The monoclonal antibody 1A1D-2 has been shown to strongly neutralize dengue virus serotypes 1, 2 and 3, primarily by inhibiting attachment to host cells. A crystal structure of its antigen binding fragment (Fab) complexed with domain III of the viral envelope glycoprotein, E, showed that the epitope would be partially occluded in the known structure of the mature dengue virus. Nevertheless, antibody could bind to the virus at 37 degrees C, suggesting that the virus is in dynamic motion making hidden epitopes briefly available. A cryo-electron microscope image reconstruction of the virus:Fab complex showed large changes in the organization of the E protein that exposed the epitopes on two of the three E molecules in each of the 60 icosahedral asymmetric units of the virus. The changes in the structure of the viral surface are presumably responsible for inhibiting attachment to cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264114     DOI: 10.1038/nsmb.1382

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  178 in total

1.  Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.

Authors:  Michelle C Sabo; Vincent C Luca; Stuart C Ray; Jens Bukh; Daved H Fremont; Michael S Diamond
Journal:  Virology       Date:  2011-11-12       Impact factor: 3.616

2.  Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo.

Authors:  Katherine L Williams; Wahala M P B Wahala; Susana Orozco; Aravinda M de Silva; Eva Harris
Journal:  Virology       Date:  2012-04-25       Impact factor: 3.616

3.  Probing the mechanism of pH-induced large-scale conformational changes in dengue virus envelope protein using atomistic simulations.

Authors:  Meher K Prakash; Alessandro Barducci; Michele Parrinello
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

4.  Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Elumalai Sunderasan; Shandar Ahmad
Journal:  J Mol Model       Date:  2010-03-16       Impact factor: 1.810

5.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

6.  Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.

Authors:  Poornima Parameswaran; Patrick Charlebois; Yolanda Tellez; Andrea Nunez; Elizabeth M Ryan; Christine M Malboeuf; Joshua Z Levin; Niall J Lennon; Angel Balmaseda; Eva Harris; Matthew R Henn
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

7.  Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle.

Authors:  Grant S Hansman; David W Taylor; Jason S McLellan; Thomas J Smith; Ivelin Georgiev; Jeremy R H Tame; Sam-Yong Park; Makoto Yamazaki; Fumio Gondaira; Motohiro Miki; Kazuhiko Katayama; Kazuyoshi Murata; Peter D Kwong
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

8.  Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera.

Authors:  Wahala M P B Wahala; Claire Huang; Siritorn Butrapet; Laura J White; Aravinda M de Silva
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

9.  Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.

Authors:  Rodrigo Velázquez-Moctezuma; Andrea Galli; Mansun Law; Jens Bukh; Jannick Prentoe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

10.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.